Introduction
============

Dengue is a mosquito-borne disease caused by dengue virus. Dengue virus, which is an RNA virus of the *Flaviviridae* family, has four serotypes, namely, DENV-1, DENV-2, DENV-3, and DENV-4. This virus is primarily transmitted by *Aedes*mosquitoes*.*Global incidence of dengue has grown dramatically in recent decades. Recent WHO report showed that more than 390 million people suffer from dengue virus infections annually worldwide [@B1]. The majority of dengue-infected patients manifest flu-like symptoms, such as fever and headache [@B2]. Meanwhile, some severe cases result in life-threatening dengue hemorrhagic fever (DHF) or dengue shock syndrome (DSS). The pathogenic mechanism of dengue is complex and remains ambiguous. Thus, no specific treatment or licensed vaccine against dengue is available. Early detection and access to proper medical care can help reduce death rate due to dengue.

Numerous assay methods or platforms have been developed for the early diagnosis of dengue infections, but these assays remain suboptimal. Viral isolation and identification is the gold standard for dengue infection but this process is time-consuming [@B3]. Moreover, the sensitivity and specificity of the methods for detecting anti-DENV IgM /IgG antibody or NS1 antigen vary in many publications [@B4]. Real time RT-PCR is sensitive, but this approach occasionally exhibits false negative or false positive results [@B5]. Thus, new biomarkers for the diagnosis, treatment, and prognosis of dengue infection are still urgently needed.

MicroRNAs (miRNAs) are endogenous non-coding single-stranded RNA molecules made of approximately 22 nucleotides. They can regulate the post-transcriptional expression of target genes by targeting mRNAs for cleavage or translational repression and play an important role in the gene regulation of organism [@B6]. Many studies showed that the abnormal expression of miRNA is closely related with the occurrence and development of diseases [@B7]-[@B11]. Moreover, numerous miRNAs have been associated with infectious diseases. These miRNAs either play an important role in delayed disease progression or help virus escape the host defense [@B12]-[@B16].

Circulating miRNAs have recently attracted considerable attention because of their potential as noninvasive biomarkers for diagnosing various diseases, such as infectious diseases. MiRNAs are highly stable in both fresh serum and plasma. Circulating miRNAs have been associated with pathophysiological states [@B17]. Several miRNAs have been reported to participate in the interaction between dengue virus and host [@B18]. For example, miR-146a facilitates replication of DENV-2 in primary human monocytes and THP-1 cells upon DENV infection by targeting TRAF6 and inhibiting IFN-beta production [@B19]. The expression of miR-24-1-5p, miR-512-5p, and miR-4640-3p in blood is recently reported to be beneficial in distinguishing mild dengue from those exhibiting liver complications [@B20]. This characteristic indicates that miRNAs may serve as biomarkers for dengue infection.

In this study, 752 miRNAs in the sera of DENV-1 patients and healthy controls were screened for different expression profiles to explore the potential biomarkers for dengue infection. The selected miRNAs were further verified by qRT-PCR. Then, diagnostic potentials and biological functions were analyzed using statistical software or bioinformatics. Moreover, correlation analysis associated with clinical parameters was performed.

Materials and Methods
=====================

Sample collection
-----------------

A total of 72 serum samples (40 patients with active DENV-1 replication and 32 healthy volunteers) were obtained from the Third People\'s Hospital of Nanhai District in Foshan City, Guangdong Province, China. Healthy controls were recruited randomly from individuals who had no clinical symptoms of infectious diseases after regular physical examination. Dengue patients enrolled in this study were confirmed to have no other infectious diseases, such as influenza A, influenza B, and HCV, and have no drug treatment. Serum samples were isolated within 1 h after receiving whole blood and then immediately stored at -80 °C until further use. This study was approved by the Ethics Committee of the Third People\'s Hospital of Nanhai District in Foshan City, Guangdong Province, China. Written informed consents were obtained from all participants. All assays were conducted according to the principles expressed in the Declaration of Helsinki.

RNA extraction
--------------

Total RNA was isolated from serum by Trizol method according to the previous method [@B21]. Briefly, 300 µL of serum was thawed on ice and centrifuged at 12000 rev/min and at 4 °C for 10 min to remove pellet and cell debris. Then, 750 μL of Trizol LS reagent were added to 250 µL supernatant. After incubation for 5 min at room temperature, 25 fmol synthetic cel-miRNA-39-3p (Syn-cel-miR-39-3p miScript miRNA Mimic, Ribobio, China) was spiked-in. The total RNA, including small RNA, was extracted using Trizol LS reagent following the manufacturer\'s instructions (Invitrogen, USA) and dissolved in 20 μL of RNase-free water. RNA was stored at -80 °C until further use.

MiRNA expression profiles using miRNA PCR arrays
------------------------------------------------

Sera from three dengue patients and 3 healthy control samples were used for miRNA PCR arrays (Human panel I+II, V4.M, KangChen Bio-tech, Shanghai, China). This assay was conducted according to the previous method with slight modification [@B21]. Relative expressions of 752 miRNAs in sera from the DENV positive group and healthy control were screened using miRNA PCR arrays. The total RNA sample was diluted to 1.5-1.8 ng/µL in nuclease-free water. Reverse transcription (RT) was conducted in an RT reaction mix (Exiqon, Denmark). cDNA was diluted by 110-fold in nuclease-free water and amplified using SYBR™ Green master mix (Exiqon, Denmark) with an ABI PRISM 7900 Real-time PCR System (Applied Biosystems, USA) according to manufacturer\'s instructions. Relative miRNA expression levels were calculated using ΔCt method per manufacturer\'s recommendations. Three miRNAs (miR-191-5p, miR-423-5p, and miR-425-5p), which show low standard deviation, were selected to normalize the 752 miRNAs from PCR array. Fold changes of \>2-fold at p \< 0.05 were used to select significantly altered miRNAs.

Verifying miRNA array data by real-time quantitative reverse transcription PCR (qRT-PCR)
----------------------------------------------------------------------------------------

Total RNAs of sera in 40 dengue patients and 32 healthy controls were subjected to further miRNA validation assay via quantitative RT-PCR (qRT-PCR) [@B21]. An miRNA assay kit (GenePharma, Shanghai, China) was used for miRNA detection and quantification. The RT reaction was performed using a PrimeScript^TM^ First Strand cDNA Synthesis Kit (Takara, Dalian, China) with an Alpha^TM^ Unit Block Assembly for DNA EngineH systems (Bio-Rad, USA) under the following reaction conditions: 30 min at 25 °C, 30 min at 42 °C, 5 min at 85 °C, and maintained at 4 °C. Selected miRNAs were confirmed by SYBR Green I dye (Takara, Dalian, China) with an ABI PRISM 7300 Real-time PCR System (Applied Biosystems, USA) under 95 °C for 3 min, followed by 40 cycles of 95 °C for 12 s, and 62 °C for 40 s. This analysis was limited to miRNAs altered significantly.

Cel-miRNA-39-3p, a non-human miRNA, was spiked into RNA samples as a control for extraction and amplification steps. MiR-191-5p and miR-16 were used as internal reference for normalization. MiRNA-16 was used for normalization of serum samples based on previous publication [@B22], and miR-191-5P was used for normalization of serum samples following the miRNA PCR arrays.

Data analysis
-------------

Initial data analysis was performed using the software supplied with the real-time PCR instrument to obtain raw Ct values. Relative expression of miRNA was calculated by the 2-ΔΔCt formula, in which ΔCt = Ct~(miRNA)~ - Ct ~(average\ of\ house-keeping\ miRNAs)~ and ΔΔCt = ΔCt~(Dengue\ patients)~- ΔCt~(Healthy\ controls)~. Subsequently, the relative quantification value underwent log 2 transformation to compare the expression levels of candidate miRNAs between healthy controls and patients. Data were expressed as mean ± SD. Statistical significance of the data was evaluated using one-way ANOVA via SPSS software. P \< 0.05 was considered statistically significant. Receiver operating characteristic (ROC) curve analysis was performed for selected miRNAs. In addition, area under the curve (AUC) values and 95% confidence intervals (CIs) were calculated to evaluate the specificity and sensitivity for detecting dengue infection. Correlation and significance analysis were conducted by SPSS software, and P \< 0.05 was considered statistically significant.

Target prediction and functional analysis in silico
---------------------------------------------------

MiRecords (<http://c1.accurascience.com/miRecords/prediction_query.php>) was selected to collect the validated targets of the selected miRNAs or predicted targets if no targets were validated. MiRecords is an integration platform of miRNA target prediction produced by 11 established miRNA target prediction programs:DIANAmicroT,MicroInspector, miRanda, MirTarget2,miTarget, NBmiRTar, PicTar, PITA,RNA22, RNAhybrid, and TargetScan/TargertScanS) to guarantee good specificity for target prediction. The functional analysis in silico about the validated or predicted targets of selected miRNA was performed on STRING 10 (<http://string-db.org>/).

Results
=======

Sample characteristics
----------------------

Six serum samples (3 controls and 3 patients) were enrolled in this study for miRNA arrays. Meanwhile, 72 serum samples (32 controls and 40 patients) were enrolled for q-PCR verification. Age and sex distribution of the two groups showed no statistically significant differences (P \> 0.05, Table [1](#T1){ref-type="table"}). However, serum aspartate transarninase (AST) and alanine aminotransferase (ALT) activities, as well as C-response protein (CRP) levels, were significantly increased in dengue-infected patients, whereas the number of white blood cells (WBC), platelets (PLT), neutrophils (NEU), and lymphocytes were significantly reduced in dengue-infected patients compared with healthy controls. No other infectious diseases were involved. Moreover, these patients belonged to newly diagnosed cases and were not subjected to any drug treatment. The results indicated that dengue-infected patients showed acute inflammatory responses in organs or tissues.

Global analysis of serum miRNA expression profiles by miRNA PCR array
---------------------------------------------------------------------

Expressions of 752 miRNAs were conducted using miRNA PCR panels to obtain a broad profile of relative miRNA expression levels in sera between dengue patients and healthy controls. Approximately 48.5% of the 752 miRNAs were undetectable in dengue patients, whereas about 52.3% of miRNAs were undetectable in healthy controls (Fig. [1](#F1){ref-type="fig"}A). No significant differences were found in the detectable or undetectable serum miRNA number observed between dengue patients and healthy control (n=3). However, volcano plots of this miRNA PCR panel showed significant fold change differences in the serum miRNA levels between dengue patients and healthy controls (Fig. [1](#F1){ref-type="fig"}B). The majority of miRNAs with significant fold changes (P\<0.05) showed an increase in dengue patients compared with healthy controls.

Aberrantly expressed miRNAs associated with dengue infection were defined to meet the following requirements: 1) Ct values \<35 either in patients or controls to ensure stable detection; 2) relative fold change ≥2 (upregulation) or ≤-2 (downregulation) between the patient and control groups; and 3) acceptable statistical significance levels for fold change, p values \<0.05. After screening, 41 upregulated and 12 downregulated miRNAs met the aforementioned conditions and might be associated with dengue infection (Tables [2](#T2){ref-type="table"} and [3](#T3){ref-type="table"}).

Confirmation of miRNA array data by qRT-PCR
-------------------------------------------

Dengue-infected patients showed acute inflammatory responses, such as reduced WBC, NEU, or lymphocyte number. We selected some miRNAs for further validation based on previous studies and bioinformatics analysis to determine whether these miRNAs are involved in the dengue pathological process. Hsa-miR-21-5p can regulate inflammation and cell proliferation [@B23]. Hsa-miR-146a-5p is mainly associated with anti-inflammation function [@B24]. Hsa-miR-590-5p is also related with inflammation and cell proliferation [@B25]. Hsa-miR-188-5p [@B26] and hsa-miR-152-3p [@B27] inhibit cell proliferation. These functions might be useful to elucidate why dengue patients manifest increased inflammation and reduced WBC, NEU, and lymphocyte number. In addition, these miRNAs showed good Ct values (average Ct value\<35) and were easily detected in sera. In this study, validation results by qRT-PCR showed that hsa-miR-21-5p, hsa-miR-590-5p, hsa-miR-188-5p, and hsa-miR-152-3p were significantly increased in dengue patients, whereas hsa-miR-146a-5p was significantly decreased (Fig. [2](#F2){ref-type="fig"}). Statistical analysis showed that these differences were significant (P\<0.05). Hsa-miR-21-5p in sera of dengue-infected patients showed the best change compared with healthy controls.

Diagnostic potential of miRNAs
------------------------------

ROC curves were plotted according to the software of GraphPad Prism 5 to explore the diagnostic potential of verified miRNAs for dengue infection (Figs. [3](#F3){ref-type="fig"}A-E). The AUCs for hsa-miR-21-5p, hsa-miR-146a-5p, hsa-miR-590-5p, hsa-miR-188-5p, and miR-152-3p were as follows: 0.9008 (95% CI: 0.8303-0.9712, P\<0.05), 0.7422 (95% CI: 0.6282-0.8561, P\<0.05), 0.7219 (95% CI: 0.5974-0.8464, P\<0.05), 0.6488 (95% CI: 0.5213-0.7764, P\<0.05), and 0.6371 (95% CI: 0.5064-0.77678, P\<0.05), respectively. Thus, hsa-miR-21-5p and hsa-miR-146a-5p seemed to have better diagnostic potential than the others.

Correlation analysis
--------------------

We selected the aforementioned miRNAs for further correlation analysis among clinical parameters because of their preferable diagnostic potential. Serum AST and ALT activities were significantly increased, whereas WBC, PLT, and NEU numbers significantly decreased in dengue patients compared with healthy controls. Interestingly, hsa-miR-21-5p showed positive correlation with serum AST and ALT activities but negative correlation with WBC, PLT, NEU, and lymphocyte numbers (Figs. [4](#F4){ref-type="fig"}A-F). However, hsa-miR-146a-5p showed negative correlation with serum AST and ALT activities, but positive correlation with WBC, PLT, NEU, and lymphocyte numbers (Figs. [4](#F4){ref-type="fig"}G-L). Hsa-miR-590-5p showed negative correlation with serum CRP level but positive correlation with WBC, NEU, and lymphocyte numbers (Figs. [4](#F4){ref-type="fig"}M-Q). Hsa-miR-188-5p and hsa-miR-152-3p showed positive correlation with serum lymphocyte number and CRP level (Figs. [4](#F4){ref-type="fig"}R-S). Hsa-miR-152-3p showed a positive correlation only with serum CRP levels (Fig. [4](#F4){ref-type="fig"}T). These results indicated that these miRNA might play key roles in regulating inflammatory response and dysfunction of blood cells.

Functional analysis in silico
-----------------------------

Among these miRNAs, miR-21 and miR-146a have well-defined functions. Hsa-miR-21-5p has 40 validated target proteins (Fig. [5](#F5){ref-type="fig"}A). These proteins form a network of interaction and may involve cell proliferation, motility, migration, locomotion, and inflammation by microRNA in cancer, p53 signaling pathway, pathway in cancer, and hepatitis B pathways (KEGG pathways). Hsa-miR-146a-5p has 35 validated target proteins (Fig. [5](#F5){ref-type="fig"}B). These proteins also form a network of interaction and may involve cell chemotaxis and inflammation by hepatitis B, herpes simplex infection, and chemokine signaling pathways (KEGG pathways). We predicted the targets of hsa-miR-590-5p, hsa-miR-188-5p, and hsa-miR-152-3p using the website of <http://c1.accurascience.com/miRecords>/. In the website, the selected targets should be predicted by at least 5 different miRNA software. We conducted functional analysis of the predicted targets of hsa-miR-590-5p, hsa-miR-188-5p, and hsa-miR-152-3p through STRING 10 (<http://string-db.org>). Hsa-miR-590-5p might involve Jak-STAT signaling pathway and inflammatory bowel disease. Hsa-miR-188-5p might invoke MAPK signaling pathway and microRNA in cancer. Hsa-miR-152-3p might involve TGF-beta signaling pathway and proteoglycans in cancer pathway. However, the majority of the predicted targets of hsa-miR-590-5p, hsa-miR-188-5p, and hsa-miR-152-3p require further validation. Nevertheless, these validated or predicted targets might indicate that the tested miRNAs mediate the inflammatory stress or cell survival and account for the complications of dengue infection.

Discussion
==========

Dengue is caused by mosquito-derived virus. This disease can lead to severe hemorrhagic fever or even lethal shock. Effective biomarkers that mirror the pathological process of dengue infectious should be established. A mature method for identifying dengue patients has been established. However, numerous problems in dengue identification, such as time-consuming or false negative/positive results, remain. Thus, more unique assay methods as alternatives for the identification of dengue patients should be formulated. Nevertheless, dengue-infected patients usually show significant reduction in the number of WBC, PLT, and NEUs [@B1], [@B28]. The mechanisms that mediate these changes remain unclear [@B29]. Circulating miRNAs can be released from various organs or tissues [@B30]. When these organs or tissues are in a pathological state, circulating miRNA can vary with this change. These released miRNAs can form vesicles and prevent degradation by nuclease [@B30]. Thus, these miRNAs can remain stable in serum or other body fluids. Emerging evidence showed that circulating miRNAs can serve as good biomarkers for various diseases [@B12], [@B31], [@B32]. In this study, we first conducted serum miRNA PCR array and found many interesting miRNAs with significant differences between dengue patients and healthy controls. Approximately half of the 752 miRNAs can be effectively detected in sera, which is consistent with the results of a previous study in which half one miRNAs can be detected [@B21]. Furthermore, a total of 53 aberrantly expressed miRNA were observed in sera of dengue-infected patients, which indicated that dengue patients showed a broad profile of serum miRNA dysfunction. These findings of dysregulated miRNAs in sera might supply important hints not only for effective biomarkers but also for elucidating the pathological process of dengue infection.

Thus, we selected hsa-miR-21-5p, hsa-miR-146a-5p, hsa-miR-590-5p, hsa-miR-188-5p, and hsa-miR-152-3p for further validation using qRT-PCR. These miRNAs were selected because of the following factors: 1) remarkable differences (more than 2-fold or less than 0.5) between the two groups; 2) good Ct values (\<35), which indicates that they might be highly abundant and can be easily assayed in sera; 3) most importantly, their association with inflammatory responses or WBC death or survival frequently observed in dengue patients based on bioinformatics analysis or published data. This characteristic might supply a key reference for the pathological process of dengue infection. ROC curve analysis showed that hsa-miR-21-5p and hsa-miR-146a-5p could well distinguish between dengue patients and healthy controls. Furthermore, hsa-miR-21-5p and hsa-miR-146a-5p had highly negative or positive correlation with the number of WBC, PLT, NEUs and lymphocytes, as well as serum ALT and AST activities, in newly diagnosed patients. Thus, these results indicate that miRNAs may serve as early biomarkers in dengue-infected patients and also likely function in the development of the disease and its complication, e.g., liver inflammation. However, exact mechanism of these miRNA-mediated dengue infection and complications need to be further elucidated.

MiR-146a basically plays an important role in regulating innate immune, inflammatory response, and virus infection [@B33]. MiR-146a exerts inflammation-regulating effects by targeting inflammatory signaling pathway [@B34]. However, the promoter of miR-146a gene has several transcription factor NF-kappaB (NF-κB) binding sites, and LPS, IL-1β, and TNF-α can induce expression of miR-146a [@B35]. Thus, miR-146a participates in the development of endotoxin tolerance [@B36]. Virus can also induce the miR-146a expression through NF-kB binding site in the miR-146a promoter [@B37]. Dengue virus infection significantly induced the expression of miR-146a in primary monocytes and THP-1 cells in vitro [@B19]. In this study, miR-146a apparently exhibited decreased extracellular secretion, which remains to be further investigated. Nevertheless, good negative correlation between miR-146a and serum AST/ALT were observed in dengue-infected patients, suggesting that miR-146a might mediate the development of liver inflammation. However, the physiological or pathological significance of reduced miR-146a in the serum of dengue-infected patients remain ambiguous. MiR-21 plays a key role in the resolution of inflammation and negative regulation of pro-inflammatory response [@B38]. Many inflammatory stimuli can trigger miR-21 induction itself. Hence, miR-21 can serve as anti-inflammatory response to balance the inflammatory stimuli. In addition to the inflammatory regulation, miR-21 promotes cell invasiveness and acts as oncomiRs [@B39] by targeting RECK. However, WBCs, lymphocytes, and NEUs were significantly reduced, indicating that WBCs, NEUs, or lymphocytes may rapidly migrate into extra-vascular tissues or organs after dengue virus invasion. MiR-590-5p promotes cell proliferation and invasion [@B40] and is also linked to inflammatory and immune responses. MiR-188 and miR-152 are apparently associated with the inhibition of cell proliferation and invasion [@B40], [@B41]. Increased miR-188 and miR-152 might inhibit the proliferation or production of WBCs, NEUs, or lymphocytes. Therefore, these results indicated that miR-146a and miR-21 may regulate inflammation response. MiR-21 and miR-590 may promote cell proliferation, whereas miR-188 and miR-152 inhibit cell proliferation. These miRNAs might form a complex network involving the delicate regulation of inflammatory stress and immune response induced by dengue viruses. These virus-stressed miRNAs indicated that they balance inflammatory or other pathological stress. Many viruses can hijack a host cell\'s machinery and evade antiviral immune responses by miRNA mechanisms [@B42]. However, these functional analyses are conducted in silico. Further experimental studies should be conducted to confirm the functions and reasons for these dysregulated serum miRNAs.

MiRNAs derived from cell cytoplasm and cell-free miRNAs can be released from cell cytoplasm to extracellular fluid by forming vesicles [@B43]. These cell-free miRNAs were relatively stable, which can well serve as new biomarkers. These miRNAs also play a key role in the regulation of physiological and pathological states in vivo. These secreted cell-free miRNAs can be taken up by other cells, so they can mediate cell-cell communications [@B44]. However, the roles of these dysfunctions of serum miRNA in the pathological process of dengue infection or other diseases are still undefined, although we have conducted functional analysis in silico. Nevertheless, these serum miRNAs have been identified as promising biomarkers for early evaluation in dengue-infected patients.

Conclusion
==========

In conclusion, miRNA PCR array assays revealed differential expression of 41 upregulated and 12 downregulated miRNAs in sera of dengue patients compared with healthy controls. Among these miRNAs, serum hsa-miR-21-5p, hsa-miR-146a-5p, hsa-miR-590-5p, hsa-miR-188-5p, and hsa-miR-152-3p were identified as potential non-invasive molecular markers for detecting dengue infection. Upregulation of serum hsa-miR-21-5p and downregulation of hsa-miR-146a-5p may serve as interesting biomarkers for early inflammation responses or other pathological process in DENV-1 patients. However, the biological functions of these miRNAs require further investigation.
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![(**A)** Percentage composition of 752 miRNAs with different threshold cycle ranges (Ct values); (**B)** Fold difference and significance levels with statistics in sera of dengue patients and healthy controls using miRNA PCR array (n=3).](ijmsv13p0195g001){#F1}

![Relative expression of selected miRNA in sera of dengue patients (n=40) and healthy controls (n=32) validated by qRT-PCR method. \*\**P*\<0.01, \**P*\<0.05 following Student *t*-test between dengue patients and healthy controls.](ijmsv13p0195g002){#F2}

![Constructed ROC curves to evaluate the diagnostic potential of serum miRNAs for dengue infection (n=72).](ijmsv13p0195g003){#F3}
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Correlation analysis between serum miRNAs and aspartate transarninase (AST) and alanine aminotransferase (ALT) activities, C-response protein (CRP) levels and the number of white blood cell (WBC), platelet (PLT), lymphocytes, and neutrophils (NEUs) in dengue patients and healthy controls (n=72).
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Interactions of targeting proteins of (**A**) hsa-miR-21-5p and (**B**) hsa-miR-146a-5p.
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###### 

Basic characteristics of healthy controls and patients enrolled in the study.

  Sample Characteristics   miRNA PCR Array   PCR Validation               
  ------------------------ ----------------- ---------------- ----------- ------------
  Number                   3                 3                32          40
  Genotype(DENV-1/other)   No                3/0              No          37/2
  DENV Ct                  No Ct             20.65±4.84       No Ct       28.62±4.83
  DENV-1 Ct                No Ct             20.88±1.49       No Ct       29.86±5.65
  Sex (male/female)        3/0               3/0              10/22       20/20
  Age (Mean ± SD)          28.3±6.4          29.3±8.7         36.6±8.5    40.7±12.7
  ALT(U/L)                 20.3±8.6          31.3±6.7         19.4±9.8    61.9±54.1
  AST(U/L)                 21.3±0.6          50.3±16.2        19.3±4.1    89.9±103.2
  WBC ( 10E9/L)            6.92±0.42         3.97±1.43        7.27±2.13   2.88±1.59
  LYM (10E/L)              2.45±0.0.21       0.56±0.49        2.11±0.49   0.62±0.25
  NEU (10E9/L)             3.74±0.27         2.65±1.18        4.59±2.05   1.78±1.48
  PLT (10E9/L)             237±81.2          105±21.9         262±72      119±78.1
  HCT (%)                  47.5±3.0          41.3±4.8         41.2±4.8    41.7±5.0
  CRP(mg/L)                0.51±0.45         17.47±10.18      2.23±4.8    5.5±7.43
  Infectious Diseases      No                DENV Only        No          DENV Only
  Anti-virus treatment     No                No               No          No

###### 

Upregulated miRNA in sera of dengue patients compared with healthy control (n=3).

  miRNA ID          Fold Difference   P value   miRNA ID          Fold Difference   P value
  ----------------- ----------------- --------- ----------------- ----------------- ---------
  hsa-miR-1972      26.7              0.0071    hsa-miR-424-5p    4.1               0.0298
  hsa-miR-518a-3p   13.7              0.0196    hsa-miR-335-5p    3.7               0.0066
  hsa-miR-1538      11.5              0.0329    hsa-miR-548a-3p   3.6               0.0061
  hsa-miR-300       10.2              0.0471    hsa-miR-320d      3.6               0.0008
  hsa-miR-21-5p     9.9               0.0100    hsa-miR-1203      3.5               0.0383
  hsa-miR-589-5p    9.4               0.0009    hsa-miR-148b-3p   3.5               0.0433
  hsa-miR-1537-3p   8.8               0.0192    hsa-miR-22-5p     3.4               0.0164
  hsa-miR-340-5p    8.7               0.0346    hsa-miR-338-5p    3.4               0.0069
  hsa-miR-1207-5p   8.6               0.0222    hsa-miR-1271-5p   3.2               0.0455
  hsa-miR-632       8.6               0.0157    hsa-miR-497-5p    3.2               0.0425
  hsa-miR-934       8.3               0.0300    hsa-miR-551a      3.1               0.0496
  hsa-miR-1227-3p   8.3               0.0248    hsa-miR-362-3p    3.0               0.0487
  hsa-miR-152-3p    7.7               0.0114    hsa-miR-223-5p    3.0               0.0300
  hsa-miR-596       7.1               0.0361    hsa-miR-708-3p    2.6               0.0226
  hsa-miR-149-3p    5.6               0.0351    hsa-miR-339-3p    2.4               0.0004
  hsa-miR-629-5p    4.9               0.0013    hsa-miR-425-3p    2.3               0.0040
  hsa-miR-188-5p    4.8               0.0431    hsa-miR-877-5p    2.3               0.0071
  hsa-miR-23a-5p    4.6               0.0196    hsa-miR-28-3p     2.2               0.0003
  hsa-miR-590-5p    4.4               0.0075    hsa-let-7d-3p     2.2               0.0003
  hsa-let-7g-3p     4.4               0.0152    hsa-miR-185-3p    2.0               0.0373
  hsa-miR-421       4.2               0.0220                                        

###### 

Downregulated miRNA in sera of dengue patients compared with healthy control (n=3).

  miRNA ID          Fold Difference   P value   miRNA ID          Fold Difference   P value
  ----------------- ----------------- --------- ----------------- ----------------- ---------
  hsa-miR-200a-3p   -10.5             0.0037    hsa-miR-885-5p    -4.0              0.0293
  hsa-miR-375       -7.5              0.0148    hsa-miR-942-5p    -3.5              0.0222
  hsa-miR-370-3p    -6.9              0.0200    hsa-miR-146a-5p   -3.4              0.0039
  hsa-miR-20b-5p    -5.4              0.0234    hsa-miR-379-5p    -2.6              0.0371
  hsa-let-7b-5p     -5.3              0.0025    hsa-miR-769-5p    -2.1              0.0412
  hsa-miR-365a-3p   -5.3              0.0181    hsa-miR-409-3p    -2.0              0.0170
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